EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Co-Diagnostics, Inc. (CODX) had EBIT Margin of -10056.68% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.26M |
|
$-25.75M |
|
$0.14M |
|
$0.12M |
|
$26.81M |
|
$-26.54M |
|
$0.32M |
|
$-26.22M |
|
$-26.26M |
|
$-25.75M |
|
$-25.75M |
|
$-25.75M |
|
$-25.84M |
|
$-26.54M |
|
$-26.27M |
|
1.33M |
|
1.33M |
|
$-16.33 |
|
$-16.33 |
|
| Balance Sheet Financials | |
$13.69M |
|
$2.27M |
|
$11.05M |
|
$24.74M |
|
$3.54M |
|
-- |
|
$0.57M |
|
$4.11M |
|
$20.63M |
|
$13.41M |
|
$20.63M |
|
2.10M |
|
| Cash Flow Statement Financials | |
$-29.14M |
|
$26.27M |
|
$11.81M |
|
$2.94M |
|
$11.88M |
|
$8.95M |
|
$2.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
46.05% |
|
-10056.68% |
|
|
EBIT Margin |
-10056.68% |
-- |
|
-9934.54% |
|
-9755.05% |
|
$-29.84M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.14 |
|
1.12 |
|
80.11 |
|
-124.81% |
|
-191.99% |
|
-104.05% |
|
-124.81% |
|
$9.85 |
|
$-22.43 |
|
$-21.90 |
|